Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
TriSalus Life Sciences, Inc. is currently managing 5 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 5 distinct examiners. The prosecution spans 4 distinct art units, indicating a broad technical scope within the medical device sector that requires specialized knowledge across different USPTO divisions.
HUDSON, AMY ROSE is identified as the busiest examiner for the portfolio, holding 1 pending office action. Since there are 5 pending office actions in total, each of the 5 distinct examiners is responsible for exactly one action. This distribution means that the company's prosecution workload is highly decentralized among various USPTO officials, which may prevent any single examiner from having a disproportionate impact on the overall portfolio.
The involvement of 4 distinct art units suggests that the company's innovations are being reviewed by multiple specialized teams. Practitioners must manage 5 separate examiner relationships and coordinate responses to 5 pending office actions. With 1 pending office action assigned to each examiner, the company faces a diverse set of technical and procedural requirements. This structure necessitates a coordinated strategy to maintain consistency across the 4 distinct art units involved.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 1 | 74.9% | +11.5% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +18.0% |
| PATEL, SHEFALI DILIP | 1 | 58.0% | +27.7% |
| JIAN, SHIRLEY XUEYING | 1 | 63.1% | +23.0% |
| HOUSTON, ELIZABETH | 1 | 37.6% | +42.9% |
| RADOMSKI, MARTIN ADAM | 1 | 32.3% | +55.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18087767 | SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER | PATEL, SHEFALI DILIP | 28d |
| 18087508 | SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE | JIAN, SHIRLEY XUEYING | — |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | — |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18027883 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | POLIAKOVA-GEORGAN, EKATERINA | 32d overdue |
| 18087767 | SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER | PATEL, SHEFALI DILIP | 28d |
| 18285063 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | HUDSON, AMY ROSE | — |
| 18087508 | SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE | JIAN, SHIRLEY XUEYING | — |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | — |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1636 | 1 |
| 1637 | 1 |
| 3792 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18285063 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | HUDSON, AMY ROSE | 1636 | §103DP | Final Rejection | — | Pending | Sep 29, 2023 |
| 18027883 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Non-Final OA | 32d overdue | Pending | Mar 22, 2023 |
| 18087767 | SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER | PATEL, SHEFALI DILIP | 3783 | §102§103§112 | Non-Final OA | 28d | Pending | Dec 22, 2022 |
| 18087508 | SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE | JIAN, SHIRLEY XUEYING | 3792 | §102§103§112 | Non-Final OA | — | Pending | Dec 22, 2022 |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | 3771 | §102§103§112 | Final Rejection | — | Pending | Nov 22, 2022 |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | 3783 | §102§103 | Final Rejection | — | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial